Navigation Links
Bunge Limited Schedules Third Quarter 2008 Earnings Release and Conference Call
Date:10/17/2008

WHITE PLAINS, N.Y., Oct. 17 /PRNewswire-FirstCall/ -- Bunge Limited (NYSE: BG), an integrated, global agribusiness and food company, will announce its results for the quarter ended September 30, 2008, on Thursday, October 23, 2008, prior to the market opening.

Bunge Limited's management will host a conference call at 10:00 a.m. EDT on October 23, 2008, to discuss the company's results.

To listen to the conference call, please dial (877) 719-9791. If you are located outside of the United States or Canada, dial (719) 325-4762. Please dial in five to 10 minutes before the scheduled start time. When prompted, enter confirmation code 3968460. The conference call will also be available live on the company's Web site at http://www.Bunge.com.

To access the webcast, click the "Investor Information" link on the Bunge homepage then select "Webcasts and News Alerts". Click on the link for the "Q3 2008 Bunge Limited Conference Call," and follow the prompts to join the call. Please go to the Web site at least 15 minutes prior to the call to register and to download and install any necessary audio software.

For those who cannot listen to the live broadcast, a replay of the call will be available later in the day on October 23, 2008, and continuing through November 22, 2008. To listen to the replay, please dial (888) 203-1112 or, if located outside of the United States or Canada, dial (719) 457-0820. When prompted, enter confirmation code 3968460. A rebroadcast of the conference call will also be available on the company's Web site. To locate the rebroadcast, select the link to "News & Events" under "Investor Information". The replay will be available in "Audio Archives". Follow t
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Bunge Reports Fourth Quarter Net Income of $245 Million
2. Solos Endoscopy, Inc. in Final Stages to Upgrade Pink Sheet Status from Limited to Current Information
3. EnrichMap Announces New Program To Reduce Medical Patient Noncompliance And Offers Healthcare Organizations A Limited Trial Test Opportunity
4. Masimo Initiates Limited Release of First-Ever Noninvasive and Continuous Hemoglobin Monitors
5. Non-Safety-Related Voluntary Recall of a Limited Portion of DAYTRANA(TM) (Methylphenidate Transdermal System) Patches Announced
6. Application for Listing of Shire Limited Ordinary Shares
7. Limited transparency in federal nanotech research may hamper development
8. Alimera Sciences, pSivida Limited Amend Medidur(TM) FA Collaboration Agreement
9. Daval International Limited Gains Approval for Phase IIB Trial of AIMSPRO(R)
10. Sunrise Biotech Holding Limited Application For Admission to PLUS
11. RoundTable Healthcare Partners Closes Sale of MedAssist Holding, Inc. to Firstsource Solutions Limited
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/3/2009)NEW DELHI, India, Dec. 3 /PRNewswire-Asia/ -- Dr. Susan Jiang, M.D., Ph.D.,Chief Science Officer at Shenzhen Beike Biotechnology Co. Ltd.,( http://www.beikebiotech.com ), spoke at a conference on Hig
(Date:12/2/2009)NEW YORK, Dec. 2 Reportlinker.com announces that a new market research report is available in its catalogue: ,, Neurostimulation - A Global Market Perspective ,, http://www.reportlinker.com/p01642
(Date:12/2/2009)NEW YORK, Dec. 2 Nearly 600 medical research executives, scientists, policy makers, and funders today convened to explore novel development approaches and innovative funding strategies at the inaugur
(Date:12/2/2009)CALGARY, Dec. 2 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc. ("Oncolytics" or the "Company") (TSX:ONC; NASDAQ: ONCY ) announced today that in connection with its previously announced unit offering
Breaking Biology Technology:Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 2Beike Biotechnology CSO Speaks on Role of Stem Cells in Treating Diabetic Foot Disease at IPA Diabetic Foot Care Conference, India 3Reportlinker Adds Neurostimulation - A Global Market Perspective 2Reportlinker Adds Neurostimulation - A Global Market Perspective 3Reportlinker Adds Neurostimulation - A Global Market Perspective 4Reportlinker Adds Neurostimulation - A Global Market Perspective 5Reportlinker Adds Neurostimulation - A Global Market Perspective 6Medical Research Leaders Explore Novel Strategies to Expedite the Search for Cures 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 2Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 3Oncolytics Biotech(R) Inc. Announces Exercise of Underwriters' Over-Allotment Option 4
... Sept. 18 Ingenuity Systems, the,leading provider...cientific,literature and data, is pleased to annou... major public-private biomedical research,partners...biological,markers to support new drug development...he founding members of the Consortium include the ...
...er 18 - Clinical Study Demonstrates Breakthrough... Capacities and Expands Potential Production,Capac... Sanofi pasteur, the vaccines division of sanofi-...ts new investigational H5N1 pandemic influenza,vac...high immune response,at the lowest dose of H5N1 an...
...e University of Pennsylvania have developed nanowi...ears and retrieving that data a thousand times fas...Flash memory and micro-drives, all using less powe...tesh Agarwal, an assistant professor in the Depart...leagues developed a self-assembling nanowire of ge...
Other Biology Technology:Ingenuity Systems Joins Biomarkers Consortium 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 2Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 3Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 4Sanofi Pasteur's Investigational H5N1 Influenza Vaccine Achieves High Immune Response at low Dosage 5Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 2Penn engineers design computer memory in nanoscale form that retrieves data 1,000 times faster 3
(Date:12/2/2009)PHILADELPHIA New study results strengthen the evidence that people who smoke cigarettes over a long period of time have an increased risk for developing colorectal cancer, even after adjusting for ot
(Date:12/2/2009)PHILADELPHIA People who smoke their first cigarette within minutes after waking up have much higher levels of cotinine, a by-product of nicotine when processed by the body, than those who wait to smo
(Date:12/2/2009)PHILADELPHIA Exposure to secondhand smoke for a prolonged period of time and in high quantity may increase the risk of breast cancer, even in women who never smoked cigarettes themselves. , "The qu
Breaking Biology News(10 mins):Cigarette smoking increases colorectal cancer risk 2Increased nicotine levels detected in those who light-up earlier 2Exposure to secondhand cigarette smoke over a lifetime increased breast cancer risk later in life 2The Wonder 28R 29 You Love Now Offers Even More of the Nutrition You Need Wonder Classic and Wonder Classic Sandwich Provide Even More Calcium and N 54290 1The Wonder 28R 29 You Love Now Offers Even More of the Nutrition You Need Wonder Classic and Wonder Classic Sandwich Provide Even More Calcium and N 54290 2Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 1Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 2Frost 26 Sullivan 3A Outsourcing Offshoring Environment Possesses Considerable Potential for Pharmacovigilance Market 54286 3Midbrook Pushes for Innovation in Medical Decontamination 54284 1Midbrook Pushes for Innovation in Medical Decontamination 54284 2Midbrook Pushes for Innovation in Medical Decontamination 54284 3
... all recommended flu vaccine appear to be less lik...timates hospitalizes 20,000 children every year. ,...Pediatrics by the University of Rochester Medical...nths (the youngest able to receive the vaccine) an...y found that, even though those years had poor mat...
...ly cause human blood and plasma to clota process t...g the course of vertebrate evolution, according to...al Institute of Allergy and Infectious Diseases, a...be published online Nov. 2 in Nature Chemical Bio...derstanding of coagulation during bacterial infect...
... universities, and inventors designing and manufac...ted economy will radically change over the next de...growing fieldknown as bioelectronicsfrom nine expe...8, from 4:45-6 p.m., in room 202, of the Electrica...ren St, at the northwest corner of Summit and Warr...
Other Biology News:Flu shot protects kids -- even during years with a bad vaccine match 2Nature study demonstrates that bacterial clotting depends on clustering 2NJIT seminar set for Nov. 6 to focus on bioelectronics -- emerging research area 2
HybriWell™ hybridization sealing system, 22 mm x 22 mm chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
HybriWell™ hybridization sealing system, 20 mm diameter chamber, 0.15 mm deep *set of 100* from Molecular Probes (Invitrogen)
Feline IL-5, Unconjugated from R&D Systems
...ess Cloning Checker Kits provide two highly effici...ter transformation without time-consuming plasmid ...d in Kit I, all you need to do is to transfer part... transformation plates into the solutions provided...
Biology Products: